Skip to main content
Top
Published in: BMC Cancer 1/2012

Open Access 01-12-2012 | Research article

LFA-1 and ICAM-1 expression induced during melanoma-endothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitro

Authors: Stephanie Ghislin, Dorian Obino, Sandrine Middendorp, Nicole Boggetto, Catherine Alcaide-Loridan, Frederique Deshayes

Published in: BMC Cancer | Issue 1/2012

Login to get access

Abstract

Background

Patients with metastatic melanoma have a poor median rate of survival. It is therefore necessary to increase our knowledge about melanoma cell dissemination which includes extravasation, where cancer cells cross the endothelial barrier. Extravasation is well understood during travelling of white blood cells, and involves integrins such as LFA-1 (composed of two chains, CD11a and CD18) expressed by T cells, while ICAM-1 is induced during inflammation by endothelial cells. Although melanoma cell lines cross endothelial cell barriers, they do not express LFA-1. We therefore hypothesized that melanoma-endothelial cell co-culture might induce the LFA-1/ICAM ligand/receptor couple during melanoma transmigration.

Methods

A transwell approach has been used as well as blocking antibodies against CD11a, CD18 and ICAM-1. Data were analyzed with an epifluorescence microscope. Fluorescence intensity was quantified with the ImageJ software.

Results

We show here that HUVEC-conditioned medium induce cell-surface expression of LFA-1 on melanoma cell lines. Similarly melanoma-conditioned medium activates ICAM-1 expression in endothelial cells. Accordingly blocking antibodies of ICAM-1, CD11a or CD18 strongly decrease melanoma transmigration. We therefore demonstrate that melanoma cells can cross endothelial monolayers in vitro due to the induction of ICAM-1 and LFA-1 occurring during the co-culture of melanoma and endothelial cells. Our data further suggest a role of LFA-1 and ICAM-1 in the formation of melanoma cell clumps enhancing tumor cell transmigration.

Conclusion

Melanoma-endothelial cell co-culture induces LFA-1 and ICAM-1 expression, thereby favoring in vitro melanoma trans-migration.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bhatia S, Tykodi SS, Thompson JA: Treatment of metastatic melanoma: an overview. Oncology (Williston Park). 2009, 23: 488-496. Bhatia S, Tykodi SS, Thompson JA: Treatment of metastatic melanoma: an overview. Oncology (Williston Park). 2009, 23: 488-496.
3.
go back to reference Springer TA: Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol. 1995, 57: 827-872. 10.1146/annurev.ph.57.030195.004143.CrossRefPubMed Springer TA: Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol. 1995, 57: 827-872. 10.1146/annurev.ph.57.030195.004143.CrossRefPubMed
4.
go back to reference Kobayashi H, Boelte KC, Lin PC: Endothelial cell adhesion molecules and cancer progression. Curr Med Chem. 2007, 14: 377-386. 10.2174/092986707779941032.CrossRefPubMed Kobayashi H, Boelte KC, Lin PC: Endothelial cell adhesion molecules and cancer progression. Curr Med Chem. 2007, 14: 377-386. 10.2174/092986707779941032.CrossRefPubMed
5.
go back to reference Butcher EC: Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991, 67: 1033-1036. 10.1016/0092-8674(91)90279-8.CrossRefPubMed Butcher EC: Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991, 67: 1033-1036. 10.1016/0092-8674(91)90279-8.CrossRefPubMed
6.
go back to reference Jung U, Norman KE, Scharffetter-Kochanek K, Beaudet AL, Ley K: Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J Clin Invest. 1998, 102: 1526-1533. 10.1172/JCI119893.CrossRefPubMedPubMedCentral Jung U, Norman KE, Scharffetter-Kochanek K, Beaudet AL, Ley K: Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J Clin Invest. 1998, 102: 1526-1533. 10.1172/JCI119893.CrossRefPubMedPubMedCentral
7.
go back to reference Dunne JL, Ballantyne CM, Beaudet AL, Ley K: Control of leukocyte rolling velocity in TNF-alpha-induced inflammation by LFA-1 and Mac-1. Blood. 2002, 99: 336-341. 10.1182/blood.V99.1.336.CrossRefPubMed Dunne JL, Ballantyne CM, Beaudet AL, Ley K: Control of leukocyte rolling velocity in TNF-alpha-induced inflammation by LFA-1 and Mac-1. Blood. 2002, 99: 336-341. 10.1182/blood.V99.1.336.CrossRefPubMed
8.
go back to reference Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA: Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986, 137: 245-254.PubMed Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA: Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986, 137: 245-254.PubMed
9.
go back to reference Roebuck KA, Finnegan A: Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol. 1999, 66: 876-888.PubMed Roebuck KA, Finnegan A: Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol. 1999, 66: 876-888.PubMed
10.
go back to reference Rothlein R, Dustin ML, Marlin SD, Springer TA: A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol. 1986, 137: 1270-1274.PubMed Rothlein R, Dustin ML, Marlin SD, Springer TA: A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol. 1986, 137: 1270-1274.PubMed
11.
go back to reference Ding ZM, Babensee JE, Simon SI, Lu H, Perrard JL, Bullard DC, Dai XY, Bromley SK, Dustin ML, Entman ML, Smith CW, Ballantyne CM: Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol. 1999, 163: 5029-5038.PubMed Ding ZM, Babensee JE, Simon SI, Lu H, Perrard JL, Bullard DC, Dai XY, Bromley SK, Dustin ML, Entman ML, Smith CW, Ballantyne CM: Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol. 1999, 163: 5029-5038.PubMed
12.
go back to reference Arfors KE, Lundberg C, Lindbom L, Lundberg K, Beatty PG, Harlan JM: A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood. 1987, 69: 338-340.PubMed Arfors KE, Lundberg C, Lindbom L, Lundberg K, Beatty PG, Harlan JM: A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood. 1987, 69: 338-340.PubMed
13.
go back to reference Fraemohs L, Koenen RR, Ostermann G, Heinemann B, Weber C: The functional interaction of the beta 2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the I domain. J Immunol. 2004, 173: 6259-6264.CrossRefPubMed Fraemohs L, Koenen RR, Ostermann G, Heinemann B, Weber C: The functional interaction of the beta 2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the I domain. J Immunol. 2004, 173: 6259-6264.CrossRefPubMed
14.
go back to reference Ostermann G, Weber KSC, Zernecke A, Schröder A, Weber C: JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol. 2002, 3: 151-158.CrossRefPubMed Ostermann G, Weber KSC, Zernecke A, Schröder A, Weber C: JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol. 2002, 3: 151-158.CrossRefPubMed
15.
go back to reference Williams LA, Martin-Padura I, Dejana E, Hogg N, Simmons DL: Identification and characterisation of human Junctional Adhesion Molecule (JAM). Mol Immunol. 1999, 36: 1175-1188. 10.1016/S0161-5890(99)00122-4.CrossRefPubMed Williams LA, Martin-Padura I, Dejana E, Hogg N, Simmons DL: Identification and characterisation of human Junctional Adhesion Molecule (JAM). Mol Immunol. 1999, 36: 1175-1188. 10.1016/S0161-5890(99)00122-4.CrossRefPubMed
16.
go back to reference Wojcikiewicz EP, Koenen RR, Fraemohs L, Minkiewicz J, Azad H, Weber C, Moy VT: LFA-1 binding destabilizes the JAM-A homophilic interaction during leukocyte transmigration. Biophys J. 2009, 96: 285-293. 10.1529/biophysj.108.135491.CrossRefPubMed Wojcikiewicz EP, Koenen RR, Fraemohs L, Minkiewicz J, Azad H, Weber C, Moy VT: LFA-1 binding destabilizes the JAM-A homophilic interaction during leukocyte transmigration. Biophys J. 2009, 96: 285-293. 10.1529/biophysj.108.135491.CrossRefPubMed
17.
go back to reference Tatsumi T, Shimazaki C, Goto H, Araki S, Sudo Y, Yamagata N, Ashihara E, Inaba T, Fujita N, Nakagawa M: Expression of adhesion molecules on myeloma cells. Jpn J Cancer Res. 1996, 87: 837-842. 10.1111/j.1349-7006.1996.tb02108.x.CrossRefPubMed Tatsumi T, Shimazaki C, Goto H, Araki S, Sudo Y, Yamagata N, Ashihara E, Inaba T, Fujita N, Nakagawa M: Expression of adhesion molecules on myeloma cells. Jpn J Cancer Res. 1996, 87: 837-842. 10.1111/j.1349-7006.1996.tb02108.x.CrossRefPubMed
18.
go back to reference Gulubova MV: Expression of cell adhesion molecules, their ligands and tumour necrosis factor alpha in the liver of patients with metastatic gastrointestinal carcinomas. Histochem J. 2002, 34: 67-77. 10.1023/A:1021304227369.CrossRefPubMed Gulubova MV: Expression of cell adhesion molecules, their ligands and tumour necrosis factor alpha in the liver of patients with metastatic gastrointestinal carcinomas. Histochem J. 2002, 34: 67-77. 10.1023/A:1021304227369.CrossRefPubMed
19.
go back to reference Liang S, Fu C, Wagner D, Guo H, Zhan D, Dong C, Long M: Two-dimensional kinetics of beta 2-integrin and ICAM-1 bindings between neutrophils and melanoma cells in a shear flow. Am J Physiol Cell Physiol. 2008, 294: C743-753. 10.1152/ajpcell.00250.2007.CrossRefPubMedPubMedCentral Liang S, Fu C, Wagner D, Guo H, Zhan D, Dong C, Long M: Two-dimensional kinetics of beta 2-integrin and ICAM-1 bindings between neutrophils and melanoma cells in a shear flow. Am J Physiol Cell Physiol. 2008, 294: C743-753. 10.1152/ajpcell.00250.2007.CrossRefPubMedPubMedCentral
20.
go back to reference Lynam E, Sklar LA, Taylor AD, Neelamegham S, Edwards BS, Smith CW, Simon SI: Beta2-integrins mediate stable adhesion in collisional interactions between neutrophils and ICAM-1-expressing cells. J Leukoc Biol. 1998, 64: 622-630.PubMed Lynam E, Sklar LA, Taylor AD, Neelamegham S, Edwards BS, Smith CW, Simon SI: Beta2-integrins mediate stable adhesion in collisional interactions between neutrophils and ICAM-1-expressing cells. J Leukoc Biol. 1998, 64: 622-630.PubMed
21.
22.
go back to reference Ghislin S, Obino D, Middendorp S, Boggetto N, Alcaide-Loridan C, Deshayes F: Junctional adhesion molecules are required for melanoma cell lines transendothelial migration in vitro. Pigment Cell Melanoma Res. 2011, 24: 504-511. 10.1111/j.1755-148X.2011.00856.x.CrossRefPubMed Ghislin S, Obino D, Middendorp S, Boggetto N, Alcaide-Loridan C, Deshayes F: Junctional adhesion molecules are required for melanoma cell lines transendothelial migration in vitro. Pigment Cell Melanoma Res. 2011, 24: 504-511. 10.1111/j.1755-148X.2011.00856.x.CrossRefPubMed
23.
go back to reference Wung BS, Ni CW, Wang DL: ICAM-1 induction by TNFalpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells. J Biomed Sci. 2005, 12: 91-101. 10.1007/s11373-004-8170-z.CrossRefPubMed Wung BS, Ni CW, Wang DL: ICAM-1 induction by TNFalpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells. J Biomed Sci. 2005, 12: 91-101. 10.1007/s11373-004-8170-z.CrossRefPubMed
24.
go back to reference Bernasconi S, Matteucci C, Sironi M, Conni M, Colotta F, Mosca M, Colombo N, Bonazzi C, Landoni F, Corbetta G: Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages. Int J Cancer. 1995, 60: 300-307. 10.1002/ijc.2910600304.CrossRefPubMed Bernasconi S, Matteucci C, Sironi M, Conni M, Colotta F, Mosca M, Colombo N, Bonazzi C, Landoni F, Corbetta G: Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages. Int J Cancer. 1995, 60: 300-307. 10.1002/ijc.2910600304.CrossRefPubMed
25.
go back to reference Altomonte M, Colizzi F, Esposito G, Maio M: Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. N Engl J Med. 1992, 327: 959-PubMed Altomonte M, Colizzi F, Esposito G, Maio M: Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. N Engl J Med. 1992, 327: 959-PubMed
26.
go back to reference Harning R, Mainolfi E, Bystryn JC, Henn M, Merluzzi VJ, Rothlein R: Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res. 1991, 51: 5003-5005.PubMed Harning R, Mainolfi E, Bystryn JC, Henn M, Merluzzi VJ, Rothlein R: Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res. 1991, 51: 5003-5005.PubMed
27.
go back to reference Ciotti P, Imro A, Scudeletti M, Rainero ML, Defferrari R, Ghiorzo P, Indiveri F, Bianchi-Scarrà G: MEL-P, a GM-CSF-producing human melanoma cell line. Melanoma Res. 1996, 6: 203-213. 10.1097/00008390-199606000-00003.CrossRefPubMed Ciotti P, Imro A, Scudeletti M, Rainero ML, Defferrari R, Ghiorzo P, Indiveri F, Bianchi-Scarrà G: MEL-P, a GM-CSF-producing human melanoma cell line. Melanoma Res. 1996, 6: 203-213. 10.1097/00008390-199606000-00003.CrossRefPubMed
28.
go back to reference Alon R, Ley K: Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol. 2008, 20: 525-532. 10.1016/j.ceb.2008.04.003.CrossRefPubMed Alon R, Ley K: Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol. 2008, 20: 525-532. 10.1016/j.ceb.2008.04.003.CrossRefPubMed
29.
go back to reference Kohn EC, Hollister GH, DiPersio JD, Wahl S, Liotta LA, Schiffmann E: Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration. Int J Cancer. 1993, 53: 968-972.CrossRefPubMed Kohn EC, Hollister GH, DiPersio JD, Wahl S, Liotta LA, Schiffmann E: Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration. Int J Cancer. 1993, 53: 968-972.CrossRefPubMed
30.
go back to reference Burns S, Hardy SJ, Buddle J, Yong KL, Jones GE, Thrasher AJ: Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil Cytoskeleton. 2004, 57: 118-132. 10.1002/cm.10163.CrossRefPubMed Burns S, Hardy SJ, Buddle J, Yong KL, Jones GE, Thrasher AJ: Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil Cytoskeleton. 2004, 57: 118-132. 10.1002/cm.10163.CrossRefPubMed
31.
go back to reference Hart IR: New evidence for tumour embolism as a mode of metastasis. J Pathol. 2009, 219: 275-276. 10.1002/path.2616.CrossRefPubMed Hart IR: New evidence for tumour embolism as a mode of metastasis. J Pathol. 2009, 219: 275-276. 10.1002/path.2616.CrossRefPubMed
32.
go back to reference Quax PH, van Muijen GN, Weening-Verhoeff EJ, Lund LR, Danø K, Ruiter DJ, Verheijen JH: Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. J Cell Biol. 1991, 115: 191-199. 10.1083/jcb.115.1.191.CrossRefPubMed Quax PH, van Muijen GN, Weening-Verhoeff EJ, Lund LR, Danø K, Ruiter DJ, Verheijen JH: Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. J Cell Biol. 1991, 115: 191-199. 10.1083/jcb.115.1.191.CrossRefPubMed
33.
go back to reference Meissauer A, Kramer MD, Hofmann M, Erkell LJ, Jacob E, Schirrmacher V, Brunner G: Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells. Exp Cell Res. 1991, 192: 453-459. 10.1016/0014-4827(91)90064-2.CrossRefPubMed Meissauer A, Kramer MD, Hofmann M, Erkell LJ, Jacob E, Schirrmacher V, Brunner G: Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells. Exp Cell Res. 1991, 192: 453-459. 10.1016/0014-4827(91)90064-2.CrossRefPubMed
34.
go back to reference Min J-K, Kim Y-M, Kim SW, Kwon M-C, Kong Y-Y, Hwang IK, Won MH, Rho J, Kwon Y-G: TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells. J Immunol. 2005, 175: 531-540.CrossRefPubMed Min J-K, Kim Y-M, Kim SW, Kwon M-C, Kong Y-Y, Hwang IK, Won MH, Rho J, Kwon Y-G: TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells. J Immunol. 2005, 175: 531-540.CrossRefPubMed
35.
go back to reference Long EO: ICAM-1: getting a grip on leukocyte adhesion. J Immunol. 2011, 186: 5021-5023. 10.4049/jimmunol.1100646.CrossRefPubMed Long EO: ICAM-1: getting a grip on leukocyte adhesion. J Immunol. 2011, 186: 5021-5023. 10.4049/jimmunol.1100646.CrossRefPubMed
36.
go back to reference Friedl P, Gilmour D: Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol. 2009, 10: 445-457. 10.1038/nrm2720.CrossRefPubMed Friedl P, Gilmour D: Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol. 2009, 10: 445-457. 10.1038/nrm2720.CrossRefPubMed
37.
go back to reference Liang S, Hoskins M, Dong C: Tumor cell extravasation mediated by leukocyte adhesion is shear rate dependent on IL-8 signaling. Mol Cell Biomech. 2010, 7: 77-91.PubMed Liang S, Hoskins M, Dong C: Tumor cell extravasation mediated by leukocyte adhesion is shear rate dependent on IL-8 signaling. Mol Cell Biomech. 2010, 7: 77-91.PubMed
38.
go back to reference Kato Y, Zhang LU, Pili R: Endothelial cells promote metastatic melanoma cell invasion via alpha(v)beta(3) integrin. AACR Meeting Abstracts. 2005, 2005: 889- Kato Y, Zhang LU, Pili R: Endothelial cells promote metastatic melanoma cell invasion via alpha(v)beta(3) integrin. AACR Meeting Abstracts. 2005, 2005: 889-
39.
go back to reference Witkowska AM, Borawska MH: Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Eur Cytokine Netw. 2004, 15: 91-98.PubMed Witkowska AM, Borawska MH: Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Eur Cytokine Netw. 2004, 15: 91-98.PubMed
40.
go back to reference Yamada M, Yanaba K, Takehara K, Sato S: Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma. Arch Dermatol Res. 2005, 297: 256-260. 10.1007/s00403-005-0605-5.CrossRefPubMed Yamada M, Yanaba K, Takehara K, Sato S: Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma. Arch Dermatol Res. 2005, 297: 256-260. 10.1007/s00403-005-0605-5.CrossRefPubMed
41.
go back to reference Giavazzi R, Foppolo M, Dossi R, Remuzzi A: Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest. 1993, 92: 3038-3044. 10.1172/JCI116928.CrossRefPubMedPubMedCentral Giavazzi R, Foppolo M, Dossi R, Remuzzi A: Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest. 1993, 92: 3038-3044. 10.1172/JCI116928.CrossRefPubMedPubMedCentral
42.
go back to reference Baton F, Deruyffelaere C, Chapin M, Prod’homme T, Charron D, Al-Daccak R, Alcaide-Loridan C: Class II transactivator (CIITA) isoform expression and activity in melanoma. Melanoma Res. 2004, 14: 453-461. 10.1097/00008390-200412000-00004.CrossRefPubMed Baton F, Deruyffelaere C, Chapin M, Prod’homme T, Charron D, Al-Daccak R, Alcaide-Loridan C: Class II transactivator (CIITA) isoform expression and activity in melanoma. Melanoma Res. 2004, 14: 453-461. 10.1097/00008390-200412000-00004.CrossRefPubMed
43.
go back to reference Martins I, Deshayes F, Baton F, Forget A, Ciechomska I, Sylla K, Aoudjit F, Charron D, Al-Daccak R, Alcaide-Loridan C: Pathologic expression of MHC class II is driven by mitogen-activated protein kinases. Eur J Immunol. 2007, 37: 788-797. 10.1002/eji.200636620.CrossRefPubMed Martins I, Deshayes F, Baton F, Forget A, Ciechomska I, Sylla K, Aoudjit F, Charron D, Al-Daccak R, Alcaide-Loridan C: Pathologic expression of MHC class II is driven by mitogen-activated protein kinases. Eur J Immunol. 2007, 37: 788-797. 10.1002/eji.200636620.CrossRefPubMed
44.
go back to reference Martins I, Sylla K, Deshayes F, Lauriol J, Ghislin S, Dieu-Nosjean M-C, Viguier M, Verola O, Charron D, Alcaide-Loridan C, Al-Daccak R: Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis. Melanoma Res. 2009, 19: 226-237. 10.1097/CMR.0b013e32832e0bc3.CrossRefPubMed Martins I, Sylla K, Deshayes F, Lauriol J, Ghislin S, Dieu-Nosjean M-C, Viguier M, Verola O, Charron D, Alcaide-Loridan C, Al-Daccak R: Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis. Melanoma Res. 2009, 19: 226-237. 10.1097/CMR.0b013e32832e0bc3.CrossRefPubMed
45.
go back to reference Sargiannidou I, Qiu C, Tuszynski GP: Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis. Semin Thromb Hemost. 2004, 30: 127-136.CrossRefPubMed Sargiannidou I, Qiu C, Tuszynski GP: Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis. Semin Thromb Hemost. 2004, 30: 127-136.CrossRefPubMed
Metadata
Title
LFA-1 and ICAM-1 expression induced during melanoma-endothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitro
Authors
Stephanie Ghislin
Dorian Obino
Sandrine Middendorp
Nicole Boggetto
Catherine Alcaide-Loridan
Frederique Deshayes
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2012
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-12-455

Other articles of this Issue 1/2012

BMC Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine